Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma

Cancer

Volumn 109, Issue 12, 2007, Pages 2566-2571

  Cannella, Sonia ^a   Santoro, Alessandra ^a,b   Bruno, Giuseppa ^a   Pillon, Marta ^c   Mussolin, Lara ^c   Mangili, Giovanna ^d   Rosolen, Angelo ^c   Aricò, Maurizio ^a  

^a Ospedale dei Bambini G Di Cristina   (Italy)

^b AO Cervello   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

Anaplastic large cell lymphoma; Germline mutation; Pediatric; Perforin gene

Indexed keywords

ADOLESCENT; ALLELE; ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GERM LINE; HETEROZYGOSITY; HUMAN; INCIDENCE; ITALY; LARGE CELL LYMPHOMA; MALE; PRESCHOOL CHILD; PRF1 GENE; PRIORITY JOURNAL; SCHOOL CHILD;

CASE-CONTROL STUDIES; CHILD; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; LYMPHOMA, LARGE-CELL, KI-1; PORE FORMING CYTOTOXIC PROTEINS; PROSPECTIVE STUDIES;

EID: 34250189190     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22718     Document Type: Article

References (37)

1. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66:848-858.
2. Delsol G, Al Saati T, Gatter C, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas: diagnostic value in so-called malignant histiocytosis. Am J Pathol. 1988;130:59-70.
3. Egeler RM, Schmitz L, Sonneveld P, Mannival C, Nesbit ME. Malignant histiocytosis: a reassessment of cases formerly classified as histiocytic neoplasms and review of the literature. Med Pediatr Oncol. 1995;25:1-7.
4. Stein H, Foss HD, Durkop H, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96:3681-3695.
5. Jaffe SE, Harris S NL, Stein H, Wardiman JW, editors. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In: World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2001.
6. Rimokh R, Magaud JP, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol. 1989;71:31-36.
7. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma [letter]. Science. 1994;263:1281-1284.
8. Wright D, McKeever P, Carter R. Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group. J Clin Pathol. 1997;50:128-134.
9. Gudgin E, Rashbass J, Pulford KJ, Erber WN. Primary and isolated anaplastic large cell lymphoma of the bone marrow. Leuk Lymphoma. 2005;46:461-463.
10. Bhagwati NS, Oiseth SJ, Abebe LS, Wiernik PH. Intravascular lymphoma associated with hemophagocytic syndrome: a rare but aggressive clinical entity. Ann Hematol. 2004;83: 247-250. Epub 2003 Dec 5.
11. Wong KF, Chan JK, Ng CS, Chu YC, Lam PW, Yuen HL. Anaplastic large cell Ki-1 lymphoma involving bone marrow: marrow findings and association with reactive hemophagocytosis. Am J Hematol. 1991;37:112-119.
12. Invernizzi R, Paulli M, Rosso R, et al. Reactive hemophagocytosis in Ki-1 positive large cell lymphoma: a case study. Haematologica. 1989;74:155-159.
13. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol. 2002;2:735-747.
14. Lowin B, Peitsch MC, Tschopp J. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol. 1995;198:1-24.
15. Trambas CM, Griffiths GM. Delivering the kiss of death. Nat Immunol. 2003;4:399-403.
16. Uellner R, Zvelebil MJ, Hopkins J, et al. Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain. EMBO J. 1997; 16:7287-7296.
17. Masson D, Peters PJ, Geuze HJ, Borst J, Tschopp J. Interaction of chondroitin sulfate with perforin and granzymes of cytolytic T-cells is dependent on pH. Biochemistry. 1990;29: 11229-11235.
18. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957-1959.
19. Arico M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry.FHL Study Group of the Histiocyte Society. Leukemia. 1996;10:197-203.
20. Burnham JM, Kreiger PA, Paessler M, Kersun LS, Cron RQ. Picture of the month: anaplastic large cell lymphoma with hemophagocytic lymphohistiocytosis. Arch Pediatr Adolesc Med. 2006;160:1177-1179.
21. Falini B, Pileri S, De Solas I, et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood. 1990;75:434-444.
22. Arico M. Peripheral T-cell lymphoma associated with hemophagocytic syndrome and hemophagocytic lymphohistiocytosis of children: do they share something? Blood. 1990;76:2163-2164.
23. Clementi R, Locatelli F, Dupre L, et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood. 2005;105:4424-4428. Epub 2005 Feb 22.
24. Clementi R, Chiocchetti A, Cappellano G, et al. Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function. Blood. 2006;108:3079-3084.
25. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood. 1998;91:2076-2084.
26. Pulford K, Lamant L, Morris SW, et al. Detection of ALK and NPM-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK-1. Blood. 1997;89:1394-1404.
27. Goransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590-597. Epub 200J Feb 6.
28. Molleran Lee S, Villanueva J, Sumegi J, et al. Characterisation of diverse PRF1 mutations leading to decreased natural 29. killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet. 2004; 41:137-144.
29. Feldmann J, Le Deist F, Ouachee-Chardin M, et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2002;117:965-972.
30. Busiello R, Adriani M, Locatelli F, et al. Atypical features of familial hemophagocytic lymphohistiocytosis. Blood. 2004; 103:4610-4612. Epub 2004 Jan 22.
31. Zur Stadt U, Beutel K, Kolberg S, et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat. 2006;27:62-68.
32. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6:715-727.
33. Corthay A, Skovseth DK, Lundin KU, et al. Primary antitumor immune response mediated by CD4+ T cells. Immunity. 2005;22:371-783.
34. Street SE, Hayakawa Y, Zhan Y, et al. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells. J Exp Med. 2004;199: 879-884. Epub 2004 Mar 8.
35. Zur Stadt U, Beutel K, Weber B, Kabisch H, Schneppenheim R, Janka G. A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. Blood. 2004; 104:1909; author reply 1910.
36. Voskoboinik I, Thia MC, Trapani JA. A functional analysis of the putative polymorphisms A91V and N252S, and 22 missense perforin mutations associated with hemophagocytic lymphohistiocytosis. Blood. 2005;105:4700-4706. Epub 2005 Mar 8.
37. Trambas C, Gallo F, Pende D, et al. A single amino acid change, A91V, lead to conformational changes which can impair processing to the active form of perforin. Blood. 2005;106:932-937.